N
Novareus
Biotech & Life Sciences · Charlotte, United States · Founded 2011
Air dis-infection devices powered by NanoStrike; the first line of protection against airborne viruses & bacteria MoreLess
Novaerus is part of WellAir – a leading provider of infection control solutions. WellAir makes the indoor world cleaner and safer. It's that important. Scientifically proven to harmonize with how we work, live, learn and play. Innovation in Air Disinfection For over a decade, Novaerus has been providing medical-grade solutions that address a global problem; unhealthy indoor air. Indoor air is the culprit for many virus-based illnesses, bacterial infections, asthma, allergies and a host of long-term health issues.
Led by a dedicated and highly skilled team of scientists, we took a fundamentally different approach to air dis-infection, which led to the transformational discovery of NanoStrike - the unique, patented technology at the core of all Novaerus portable air dis-infection devices today. This nanotechnology inactivates all airborne microorganisms on contact providing the first line of protection against viruses and bacteria.
Utilizing NanoStrike technology, Novaerus air disinfection devices help to prevent the spread of infection in thousands of hospitals, senior living facilities, IVF clinics, dental offices, schools and homes around the world.
Company overview
Novareus company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2011
- Headquarters
- Charlotte, United States
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 26.3
Valuation & funding
Novareus funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Feb 2016 | $15M | $59M | Fidelity Investments · Summit Bridge Capital | — |
| SEED✓Equity / VC | Dec 2015 | — | — | Summit Bridge Capital · F-Prime · Polaris Partners | — |
| EARLY VC✓Equity / VC | Nov 2014 | $10M | $40M | Polaris Partners · F-Prime | — |
Financials
Revenue over time
Available revenue history. Fields without reported data are omitted.
| Year | Revenue | Growth |
|---|---|---|
| 2026 | $3.9M | 0% |
| 2025 | $3.9M | 0% |
| 2024 | $3.9M | 0% |
| 2023 | $3.9M | 0% |
| 2022 | $3.9M | 0% |
| 2021 | $3.9M | +21.9% |
| 2020 | $3.2M | — |
Growth signals
Novareus website traffic
Latest recorded traffic for Novareus is 310 monthly website visits, down 83.7% over the last three months.
Comparisons
Novareus compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Novareus's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Novareus has talent and traffic
In the news
Latest news about Novareus
Recent press, funding announcements, and product moves mentioning Novareus — open to read from the original sources.
Market sentiment
What the market is saying about Novareus
An AI-synthesized read of the highest-engagement posts about Novareus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Novareus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.